CR9443A - Vacuna de toxoide de c. perfringens alfa - Google Patents

Vacuna de toxoide de c. perfringens alfa

Info

Publication number
CR9443A
CR9443A CR9443A CR9443A CR9443A CR 9443 A CR9443 A CR 9443A CR 9443 A CR9443 A CR 9443A CR 9443 A CR9443 A CR 9443A CR 9443 A CR9443 A CR 9443A
Authority
CR
Costa Rica
Prior art keywords
perfringens
alfa
vaccines
toxoid vaccine
present
Prior art date
Application number
CR9443A
Other languages
English (en)
Inventor
Jayappa Huchappa
O'connell Kevin
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36820082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9443(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of CR9443A publication Critical patent/CR9443A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion describe vacunas que comprenden toxoides alfa de un Tipo C. perfringens, sus fragmentos antigenicos, fragmentos antigenicos inactivos de toxinas alfa de un Tipo C. perfrigens, o cualquiera de sus combinaciones. La presente invencion ademas describe metodos para el uso de estas vacunas en la proteccion de animales contra enfermedades clostridiales. La presente invencion describe tambien metodos para la elaboracion de estas vacunas.
CR9443A 2005-04-18 2007-10-16 Vacuna de toxoide de c. perfringens alfa CR9443A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67228905P 2005-04-18 2005-04-18

Publications (1)

Publication Number Publication Date
CR9443A true CR9443A (es) 2008-02-20

Family

ID=36820082

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9443A CR9443A (es) 2005-04-18 2007-10-16 Vacuna de toxoide de c. perfringens alfa

Country Status (25)

Country Link
US (2) US8980283B2 (es)
EP (1) EP1874344B1 (es)
JP (2) JP5243951B2 (es)
KR (1) KR20080005277A (es)
CN (1) CN101198352B (es)
AR (1) AR054251A1 (es)
AU (1) AU2006236365B2 (es)
BR (1) BRPI0610843B1 (es)
CA (1) CA2606180C (es)
CR (1) CR9443A (es)
DK (1) DK1874344T3 (es)
ES (1) ES2583484T3 (es)
IL (1) IL186701A0 (es)
MA (1) MA29406B1 (es)
MX (1) MX2007013053A (es)
MY (1) MY149604A (es)
NZ (1) NZ562637A (es)
PE (1) PE20061398A1 (es)
RU (1) RU2434638C2 (es)
SG (1) SG186672A1 (es)
TN (1) TNSN07387A1 (es)
TW (1) TWI311057B (es)
UA (1) UA98099C2 (es)
WO (1) WO2006113772A1 (es)
ZA (1) ZA200709516B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
PL2004220T3 (pl) * 2006-03-30 2015-11-30 Zoetis Services Llc Sposoby i kompozycje do szczepienia drobiu
BRPI0711572A2 (pt) * 2006-04-17 2011-11-16 Schering Plough Ltd organismos recombinantes atenuados de clostridium e vacinas
US7745175B2 (en) 2006-10-27 2010-06-29 Dow Agrosciences Llc Polynucleotides encoding Clostridium perfringens alpha toxin proteins
US20100062025A1 (en) * 2006-11-20 2010-03-11 Intervet International B.V. Use of Clostridium perfringens type C bacterium for the manufacture of a vaccine
US7820171B2 (en) * 2007-04-12 2010-10-26 Pradip Maiti Use of avian anti-methanogen antibodies for reduction of methane production
EP2162150A4 (en) * 2007-06-22 2011-10-12 Univ Guelph VACCINE AGAINST CLOSTRIDIUM PERFRINGENS
US8956628B2 (en) * 2007-12-13 2015-02-17 Zoetis Products Llc Bacteriophage preparations and method of use thereof
US9052304B2 (en) 2009-03-13 2015-06-09 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
US8916162B2 (en) 2010-02-20 2014-12-23 Alexey Gennadievich Zdanovsky Botulinum neurotoxin antigenic compositions and methods
WO2011151941A1 (ja) * 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
CN102008720B (zh) * 2010-07-20 2015-02-25 东北农业大学 抗魏氏梭菌病转基因植物疫苗及其制作方法
EP2793934B1 (en) * 2011-12-23 2017-08-23 Merz Pharma GmbH & Co. KGaA Novel method for the manufacturing of di-chain proteins for use in humans
CN102657683B (zh) * 2012-06-02 2014-05-07 哈尔滨工业大学 一种免疫类毒素的制备方法
CN102698259B (zh) * 2012-06-12 2017-02-08 北京中海生物科技有限公司 一种鸡坏死性肠炎（a型）灭活疫苗制备方法
CN102688484B (zh) * 2012-06-13 2016-03-30 北京中海生物科技有限公司 一种鸡坏死性肠炎（c型）灭活疫苗的生产方法
ES2759583T3 (es) 2012-10-26 2020-05-11 Intervet Int Bv Vacunas de Salmonella de protección cruzada
CN103463632B (zh) * 2013-09-05 2016-01-06 山东农业大学 牛羊肠毒血症的d型产气荚膜梭菌类毒素疫苗的制备方法
FR3012964A1 (fr) * 2013-11-12 2015-05-15 Seppic Sa Vaccins adjuves pour vaccination aviaire in ovo
CN103861094A (zh) * 2014-03-27 2014-06-18 山东农业大学 一种产气荚膜梭菌α毒素基因工程疫苗及其应用
CN104131022A (zh) * 2014-08-01 2014-11-05 中国农业科学院兰州兽医研究所 产气荚膜梭菌α、β1、β2、ε毒素共表达载体及其构建方法和表达方法
CN104531731B (zh) * 2014-12-15 2018-06-26 中国人民解放军军事医学科学院军事兽医研究所 产气荚膜梭菌α毒素人源化单链抗体7D
CN104531730B (zh) * 2014-12-15 2018-07-17 中国人民解放军军事医学科学院军事兽医研究所 产气荚膜梭菌α毒素人源化单链抗体8B
CN104531867B (zh) * 2014-12-25 2017-03-29 湖北省农业科学院畜牧兽医研究所 产气荚膜梭菌肠毒素阳性菌双重荧光定量pcr快速检测试剂盒
EP3112474A1 (en) * 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
CA3050724A1 (en) 2017-01-23 2018-07-26 University Of Florida Research Foundation, Incorporated Induction of protective immunity against antigens
WO2018159476A1 (ja) * 2017-02-28 2018-09-07 一般財団法人阪大微生物病研究会 多価ワクチン
BR112019025019A2 (pt) * 2017-05-31 2020-06-30 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food polipeptídeo isolado de pilus de clostridium perfringens, polipeptídeo imunogênico, vetor, vacina, uso de um polipeptídeo imunogênico, método de tratamento, anticorpo, método para detectar infecção e método para detectar um polipeptídeo imunogênico
JP7349366B2 (ja) * 2017-06-09 2023-09-22 ヒプラ シエンティフィック エセ．エレ．ウ． クロストリジウム類毒素を含むワクチン
CN111182920B (zh) * 2017-08-04 2023-09-12 佛罗里达大学研究基金公司 针对抗原的保护性免疫的诱导
CN107596361B (zh) * 2017-09-12 2020-08-14 浙江海隆生物科技有限公司 牛a型产气荚膜梭菌的亚单位疫苗及其制备方法和应用
CN107875377B (zh) * 2017-11-06 2020-01-03 山东农业大学 一种e型产气荚膜梭菌类毒素疫苗的制备方法
CN109954135B (zh) * 2017-12-25 2023-01-31 金宇保灵生物药品有限公司 牛a型产气荚膜梭菌灭活类毒素疫苗及其制备方法
WO2019166830A1 (en) * 2018-03-02 2019-09-06 One Health Ventures Ltd Epsilon toxin from clostridium perfringens as a vaccine
CN108578686B (zh) * 2018-04-23 2022-07-01 杨凌凯瑞生物科技有限公司 一种制备羊梭菌病基因工程亚单位疫苗的方法
CN109111509B (zh) * 2018-09-19 2021-08-13 天康制药(苏州)有限公司 腐败梭菌α毒素突变体、表达其的基因、制备方法和腐败梭菌疫苗
CN111500482B (zh) * 2019-01-31 2023-09-05 内蒙古金宇保灵生物技术研究院有限公司 一种羊a型产气荚膜梭菌菌株及其灭活疫苗和疫苗制备方法
CN109943507B (zh) * 2019-03-26 2021-08-17 中国兽医药品监察所 一种兽用a型产气荚膜梭菌类毒素的制备方法及其应用
CN110041437B (zh) * 2019-04-29 2020-12-25 中国兽医药品监察所 一种无毒性破伤风毒素和诺维梭菌α毒素重组融合蛋白
CN115477699A (zh) * 2022-10-14 2022-12-16 华中农业大学 抗产气荚膜梭菌卵黄抗体及其制备方法
CN118006636B (zh) * 2024-01-19 2025-12-30 扬州大学 一种鸡产气荚膜梭菌Mbp基因及其应用
CN120384029B (zh) * 2025-06-27 2025-10-28 国药集团动物保健股份有限公司 一株猪源a型产气荚膜梭菌及其在疫苗制备中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2257230B1 (es) * 1973-09-14 1976-11-19 Agronomique Inst Nat Rech
SU627611A1 (ru) * 1977-09-30 1980-02-05 В.П. Землякова Вакцинный препарат в.п. земл ковой против клостридиозов животных и птиц
NZ253189A (en) * 1992-05-20 1996-08-27 Secr Defence Peptides comprising amino acid sequences of clostridium perfringens alpha toxins, vaccines containing them, antibodies and their use
WO1994022476A1 (en) * 1993-03-29 1994-10-13 Pfizer Inc. Multicomponent clostridial vaccines using saponin adjuvants
US6048535A (en) * 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
RU2129441C1 (ru) * 1997-12-10 1999-04-27 Пирожков Михаил Константинович Вакцина, ассоциированная против анаэробной энтеротоксемии и эшерихиоза поросят
AU2003231818B2 (en) * 2002-05-21 2007-04-19 Intervet International B.V. Methods for the in vitro culture of Sporozoea sp. and user thereof
WO2005002509A2 (en) 2003-06-09 2005-01-13 Corixa Corporation Dna vectors
WO2005016383A1 (en) 2003-08-14 2005-02-24 Merial Limited Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen
CA2583113C (en) * 2004-10-05 2015-11-10 Diversa Corporation Compositions comprising an antigen and a promiscuous t-cell epitope
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
US20100062025A1 (en) * 2006-11-20 2010-03-11 Intervet International B.V. Use of Clostridium perfringens type C bacterium for the manufacture of a vaccine

Also Published As

Publication number Publication date
NZ562637A (en) 2010-06-25
AU2006236365A1 (en) 2006-10-26
JP2008536936A (ja) 2008-09-11
JP5243951B2 (ja) 2013-07-24
US20150140033A1 (en) 2015-05-21
WO2006113772A1 (en) 2006-10-26
DK1874344T3 (en) 2016-09-19
EP1874344B1 (en) 2016-06-08
SG186672A1 (en) 2013-01-30
CA2606180C (en) 2016-09-13
RU2434638C2 (ru) 2011-11-27
MY149604A (en) 2013-09-13
CA2606180A1 (en) 2006-10-26
RU2007142337A (ru) 2009-05-27
CN101198352B (zh) 2011-07-27
MA29406B1 (fr) 2008-04-01
US8980283B2 (en) 2015-03-17
AU2006236365B2 (en) 2012-02-02
UA98099C2 (uk) 2012-04-25
BRPI0610843A2 (pt) 2010-07-27
MX2007013053A (es) 2008-01-14
TW200719910A (en) 2007-06-01
EP1874344A1 (en) 2008-01-09
KR20080005277A (ko) 2008-01-10
IL186701A0 (en) 2008-02-09
ES2583484T3 (es) 2016-09-21
ZA200709516B (en) 2008-11-26
AR054251A1 (es) 2007-06-13
TWI311057B (en) 2009-06-21
PE20061398A1 (es) 2007-01-15
JP2012062330A (ja) 2012-03-29
CN101198352A (zh) 2008-06-11
BRPI0610843B1 (pt) 2021-11-30
TNSN07387A1 (en) 2009-03-17
US9662380B2 (en) 2017-05-30
US20060233825A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
CR9443A (es) Vacuna de toxoide de c. perfringens alfa
ECSP099079A (es) Mimeticuerpos de peptido-1 similar a glucagon de humano, composiciones, metodos y usos
CO2019013707A2 (es) Polinucleótidos de aadc para el tratamiento de la enfermedad de parkinson
CR11122A (es) Vacuna de influenza de emulsion de aceite en agua
BRPI0509606A (pt) emulsões de óleo-em-água microfluidizadas e composições para vacinas
BRPI0509528A (pt) corpos imitação de glp-1 humana, composições, processos e usos
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
CR10726A (es) Vacuna que comprende un adyuvante de emulsion de aceite en agua
CO6331297A2 (es) Composiciones adyuvantes novedosas
BRPI0510430A (pt) composições e métodos para vacinação mucosal
CR20130016A (es) ANTICUERPOS PEPTIDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS
CR9606A (es) Anticuerpos anti-proteina quinoatrayente de monocitos-1, composiciones, metodos y usos
AR060565A1 (es) Vacuna para la gripe aviaria y metodos de uso
NI201100025A (es) Métodos de administración de las formulaciones tópicas antimicóticas para el tratamiento de las infecciones por hongos.
CU23608A3 (es) Vacuna para la tuberculosis ureasa deficiente con eficacia mejorada
GT201100145A (es) Vacuna recombinante para influenza aviar y sus usos
NZ630868A (en) Acellular pertussis vaccine
MX2016001695A (es) Composiciones inmunogenas de combinacion.
BR112014020025A8 (pt) Vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas
WO2007024947A3 (en) Canine influenza vaccines
BR112019004303A2 (pt) composição de conjugados multivalentes de polissacarídeo capsular pneumocócico-proteína portadora e uso da mesma
GT200500094A (es) Formulaciones liquidas administrables pro via dermica para combatir artropodos parasitos en animales
SV2006002290A (es) Nonadepsipeptidos acilados ii ref. bhc041327-sv
ECSP12011951A (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnóstico para una enfermedad parasitaria
HN2003000104A (es) Derivados de ciclopenteno